Altshuler Shaham LTD Uro Gen Pharma Ltd. Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.92 - $9.73 $116,624 - $191,681	-19,700 Reduced 46.35%	22,801 $199,000
Q1 2021 May 13, 2021	BUY	$17.99 - $26.96 $341,809 - $512,240	19,000 Added 80.85%	42,501 $828,000
Q1 2020 May 12, 2020	SELL	$13.68 - $34.6 $36,539 - $92,416	-2,671 Reduced 10.21%	23,501 $419,000
Q3 2019 Nov 12, 2019	BUY	$23.83 - $36.44 $6,672 - $10,203	280 Added 1.08%	26,172 $620,000
Q2 2019 Aug 06, 2019	BUY	$32.75 - $40.35 $39,103 - $48,177	1,194 Added 4.83%	25,892 $931,000
Q4 2018 Feb 11, 2019	BUY	$38.35 - $50.39 $947,168 - $1.24 Million	24,698 New	24,698 $1.06 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.